Diagnostic Value of Simple Immune-chromatographic Test for Rapid Detection of Clostridium difficile Infection

*Corresponding Author: Sahar M. Fayed Clinical and Chemical Pathology Department, Faculty of Medicine, Banha University Tel.: 01227154603 saharmohamadfayed@gmail.com Background: Clostridium difficile is a very important cause fo antibiotic-associated diarrhea and pseudomembranous colitis. Diagnosis of C. difficile mainly relies on toxin detection in stool specimens from individuals with suspected disease. Objective: is to introduce to our microbiology laboratory of a simple test that may be rapid, cheap and easily manipulated than conventional methods for effective diagnosis of C. difficile infection. Methodology: Stool samples from sixty eight hospitalized patients developing CDI like symptoms were subjected to culture on CCFA, detection of toxins A and/or B by X/pect test (directly from stool samples and from culture isolates) and Real time PCR for detection of tcdA/ tcdB toxin genes. Results: Toxigenic C. difficile was detected in (22.1%) of suspected cases using tcdA/ tcdB real time PCR which was the gold standard method in our study. The positive rate for the direct X/pect test was 13.2% and for the indirect test was 14.7%. The sensitivity of direct X/pect test was 60%, specificity was 100%, PPV was 100%, and NPV was 89.8% with 91.2% agreement between the direct assay and real time PCR. While, the validity values for the indirect test was 66.7%, 100%, 100% & 91.4% for sensitivity, specificity, PP and NP values respectively, with 92.6% agreement between both assays. Antibiotic intake and recent hospitalization were the most commonly encountered risk factors, followed by number of hospitalization days. Penicillins and cephalosporins were the most frequently associated antibiotics, followed by clindamycin Conclusions: Using X/pect test can combine accurate results with simple procedure that offers results within 20 minutes. Although it is accompanied with low sensitivity and high rate of false-negative results, X/pect test may be of great benefit to practitioners particularly when you need STAT testing or 24 hour/ 7 days coverage. Further, it can be used as a preliminary screening approach allowing patients to be treated early and correctly in order to shorten the duration of symptoms and avoid complications.

[1]  M. Azimirad,et al.  Prevalence of binary-toxin genes (cdtA and cdtB) among clinical strains of Clostridium difficile isolated from diarrheal patients in Iran , 2018, Gastroenterology and hepatology from bed to bench.

[2]  S. Kamiya,et al.  Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay , 2018, Journal of Clinical Microbiology.

[3]  O. Muñoz,et al.  Antibiotic-associated diarrhea: Clinical characteristics and the presence of Clostridium difficile , 2017 .

[4]  S. Boisset,et al.  Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy , 2016, SpringerPlus.

[5]  A. Ofosu Clostridium difficile infection: a review of current and emerging therapies , 2016, Annals of gastroenterology.

[6]  E. A. Elgohary,et al.  Prevalence and Severity of Binary Toxin Producing Clostridium Difficile Isolates in ICU, Zagazig University Hospitals , 2016 .

[7]  R. Dessau,et al.  Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  R. Jump Clostridium difficile infection in older adults. , 2013, Aging health.

[9]  D. Williamson,et al.  Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword. , 2013, American journal of infection control.

[10]  N. Dendukuri,et al.  Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type. , 2012, Diagnostic microbiology and infectious disease.

[11]  P. Pottinger,et al.  The Diagnosis of Clostridium difficile Infection , 2012 .

[12]  Anne Elixhauser,et al.  Clostridium Difficile Infections (CDI) in Hospital Stays, 2009 , 2012 .

[13]  N. Khardori Rapid Stool-Based Diagnosis of Clostridium difficile Infection by Real-Time PCR in a Children's Hospital , 2011 .

[14]  A. Choure,et al.  Antibiotic-Associated Diarrhea and Clostridium difficile , 2010 .

[15]  A. Charlett,et al.  Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods , 2009, Journal of Clinical Microbiology.

[16]  J. Songer,et al.  Algorithm Combining Toxin Immunoassay and Stool Culture for Diagnosis of Clostridium difficile Infection , 2009, Journal of Clinical Microbiology.

[17]  Richard Holliman,et al.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. , 2008, The Lancet. Infectious diseases.

[18]  A. Ananthakrishnan,et al.  Clostridium difficile and inflammatory bowel disease. , 2008, Inflammatory bowel diseases.

[19]  E. Bouza,et al.  Comparison of Three Commercial Methods for Rapid Detection of Clostridium difficile Toxins A and B from Fecal Specimens , 2008, Journal of Clinical Microbiology.

[20]  J. Rosenblatt,et al.  Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection , 2008, Journal of Clinical Microbiology.

[21]  O. Vandenberg,et al.  Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease. , 2008, Clinical laboratory.

[22]  Pranav Jain,et al.  Detection of Clostridium difficile Toxin: Comparison of Enzyme Immunoassay Results with Results Obtained by Cytotoxicity Assay , 2007, Journal of Clinical Microbiology.

[23]  M. Delmée,et al.  Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains. , 2007, Journal of medical microbiology.

[24]  T. Louie,et al.  Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada , 2006, Journal of Clinical Microbiology.

[25]  J. Ballard,et al.  Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.

[26]  T. Wilkins,et al.  Clostridium difficile Testing: after 20 Years, Still Challenging , 2003, Journal of Clinical Microbiology.

[27]  A. Shehabi,et al.  Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients. , 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[28]  C. Kelly,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[29]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[30]  D. Citron,et al.  Selective and differential medium for isolation of Clostridium difficile , 1979, Journal of clinical microbiology.